Bronchiolitis Obliterans Syndrome

Bronchiolitis obliterans syndrome is the name lung-transplant and blood stem-cell transplant teams use for a specific pattern of chronic, progressive small-airway scarring that narrows and finally blocks the tiniest breathing tubes (bronchioles). The scar tissue forms inside and around these airways after an injury—often related to immune reactions after transplant, certain severe infections, or toxic chemical exposures. When the tubes narrow, air gets trapped, oxygen levels fall with activity, and people develop persistent breathlessness, cough, and wheeze that do not fully go away. In lung-transplant recipients, BOS is a principal form of chronic lung allograft dysfunction (CLAD) and is defined and staged mainly by declines in spirometry (especially FEV₁) after other causes have been ruled out. jhltonline.org+1

Bronchiolitis obliterans syndrome (BOS) is a long-term disease that narrows and scars the very small airways of the lungs. It most often happens after lung transplant or after bone-marrow/hematopoietic cell transplant. People feel breathless, have a dry cough, and cannot blow air out well. Doctors diagnose BOS when lung tests show a lasting drop in FEV1 (how much air you can blow out in one second) and CT scans show air trapping or a mosaic pattern. The goal of care is to slow scarring, reduce inflammation, and protect the transplanted organ or tissues. PubMed+3Default+3publications.ersnet.org+3

Other names

• Constrictive bronchiolitis (describes the scarring “constricting” the airway)

• Obliterative bronchiolitis (describes the airway lumen being “obliterated” by scar)

• Post-infectious bronchiolitis obliterans (PIBO) (when it follows a severe infection, more often in children)

• “Popcorn lung” (a colloquial term from workplace outbreaks linked to diacetyl, a flavoring chemical)

• BOS (the transplant-specific clinical syndrome within CLAD) BioMed Central+2CDC+2

Types

1. Post–lung transplant BOS (CLAD-BOS phenotype). A chronic rejection pattern recognized and staged by FEV₁ decline from the patient’s best post-transplant baseline after excluding other causes. jhltonline.org+1

2. Post–hematopoietic cell transplant BOS. A lung manifestation of chronic graft-versus-host disease (cGVHD) with similar symptoms, imaging, and physiology to transplant BOS. PubMed+1

3. Post-infectious bronchiolitis obliterans (PIBO). Follows severe lower respiratory infections (classically adenovirus in children) and causes long-term airway obstruction. BioMed Central+1

4. Occupational/toxic-inhalational constrictive bronchiolitis. Triggered by irritant gases or flavoring chemicals such as diacetyl; often shows mosaic air-trapping on CT and fixed obstruction on spirometry. CDC+2PMC+2

5. Autoimmune/Connective-tissue–associated constrictive bronchiolitis. Seen with disorders like rheumatoid arthritis; symptoms can be persistent despite treatment and may progress slowly. PMC+1

6. Drug-associated constrictive bronchiolitis (rare). Reported with a few agents (e.g., penicillamine, gold, sulfasalazine, busulfan), usually in case reports/series. jaypeedigital.com+2U.S. Pharmacist+2

---

Causes

1. Lung transplantation (chronic rejection/CLAD-BOS). Alloimmune injury drives chronic airway inflammation and scarring, producing progressive airflow obstruction measured by falling FEV₁. jhltonline.org

2. Allogeneic hematopoietic cell transplantation (cGVHD-BOS). Donor immune cells attack airway tissues, causing small-airway fibrosis months after transplant. PubMed

3. Adenovirus pneumonia (especially in children). Severe epithelial injury heals with fibrotic narrowing of bronchioles (PIBO). BioMed Central

4. RSV, measles, and Mycoplasma infections. These infections can trigger post-infectious small-airway scarring in susceptible patients. Karger Publishers

5. Diacetyl exposure (flavoring-related lung disease). Workplace exposure damages bronchioles, leading to irreversible obliteration; early CT shows mosaic air-trapping. CDC+1

6. Nitrogen dioxide (silo-filler’s gas) and other irritant gases (e.g., chlorine, ammonia). High-level exposures can cause delayed airway scarring after the acute injury resolves. PMC

7. Rheumatoid arthritis–associated airway disease. Autoimmune airway inflammation can remodel and constrict bronchioles over time. PMC

8. Inflammatory bowel disease–associated bronchiolitis (rare). Immune dysregulation extends to the lungs and can involve small airways. publications.ersnet.org

9. Systemic lupus erythematosus (rare). Autoimmune involvement may include small-airway fibrosis. ejinme.com

10. Gastroesophageal reflux with chronic aspiration (post-transplant risk factor). Micro-aspiration can perpetuate airway injury and accelerate BOS in transplant recipients. jhltonline.org

11. Airway infection after transplant (e.g., Pseudomonas, CMV). Recurrent infections are recognized BOS risk modifiers by sustaining inflammation. jhltonline.org

12. Acute rejection episodes after lung transplant. Repeated immune attacks increase long-term risk of BOS. jhltonline.org

13. Air pollution and occupational dust/fume mixtures (non-specific). Chronic inhaled irritants can contribute to bronchiolar injury in susceptible workers. PMC

14. Severe toxic inhalation disasters (e.g., industrial spills). High-dose exposures can culminate in constrictive bronchiolitis after apparent recovery. PMC

15. Penicillamine (rare). Case reports link this DMARD to bronchiolitis obliterans in RA patients. JAMA Network

16. Gold salts (rare). Historical reports associate chrysotherapy with bronchiolitis obliterans. U.S. Pharmacist

17. Sulfasalazine (rare). Reported in drug-related small-airway disease literature. jaypeedigital.com

18. Busulfan (rare). Alkylating chemotherapy associated with bronchiolar fibrosis in case literature. jaypeedigital.com

19. Post-viral bronchiolitis in adults (uncommon). Adult cases after severe viral illness have been described, usually with fixed obstruction. Karger Publishers

20. Chronic graft-versus-host disease–related airway bronchiolitis beyond BOS definitions. Broader cGVHD immune activity can involve bronchioles and evolve into BOS. PMC

---

Symptoms

1. Shortness of breath, especially on exertion. Airway narrowing traps air, so walking or climbing stairs causes breathlessness that gradually worsens. PMC

2. Persistent dry cough. Ongoing airway irritation and remodeling provoke a non-productive cough. PMC

3. Wheezing. The narrowed bronchioles generate musical whistling sounds, often not fully relieved by inhalers. PMC

4. Exercise intolerance and easy fatigue. Less oxygen reaches the blood during activity, making even routine tasks feel hard. PMC

5. Chest tightness. Some people feel a band-like constriction during flares or exertion because of air trapping. PMC

6. Frequent chest infections or slow recovery from colds. Damaged small airways clear mucus poorly, so infections linger. jhltonline.org

7. Noisy breathing at night or with colds. Small-airway narrowing can sound worse when lying flat or during viral illnesses. BioMed Central

8. Prolonged cough after a severe pneumonia (children). In PIBO, cough and breathlessness persist months after the initial infection. BioMed Central

9. Daily activity takes longer. People pace themselves or take rests on flat ground. PMC

10. Need for rescue inhalers without full relief. Because the obstruction is “fixed,” bronchodilators help less than in asthma. jhltonline.org

11. Low oxygen with walking. A fingertip oximeter may show drops during the 6-minute walk test. jhltonline.org

12. Persistent crackles or wheeze on exam. Clinicians may hear diffuse abnormal sounds even when the chest X-ray is near normal. BioMed Central

13. Symptoms months to years after transplant. In BOS, problems usually appear later rather than immediately after surgery. jhltonline.org

14. Cough/wheeze with workplace exposures. Symptoms can worsen during shifts in flavoring or chemical plants. CDC

15. Slow, insidious onset in autoimmune disease. People with RA can develop stubborn, slowly progressive airflow obstruction. PMC

---

Diagnostic tests

A) Physical examination

1. Vital signs and work of breathing. Clinicians look for fast breathing, use of accessory muscles, and low oxygen at rest or with talking—clues to significant air trapping. jhltonline.org

2. Chest auscultation. Wheezes from narrowed bronchioles or crackles from peripheral airway disease can be heard, even when the chest X-ray is normal. BioMed Central

3. Percussion and chest expansion. Hyperinflation from air trapping may reduce diaphragmatic movement and alter percussion tones. jhltonline.org

4. Clubbing and cyanosis check. Long-standing hypoxemia may show as bluish lips or clubbing in advanced disease. PMC

5. Infection signs. Fever, purulent sputum, or focal findings prompt tests to rule out infection—a required step before labeling declines as BOS in transplants. American Thoracic Society

B) Manual bedside/functional tests

6. Spirometry with bronchodilator testing. Hallmark: fixed airflow obstruction with reduced FEV₁ and often a low FEV₁/FVC; little reversibility compared with asthma. In BOS, specific FEV₁ declines from baseline stage the syndrome. Default+1

7. Body plethysmography (lung volumes). Shows air trapping (↑ residual volume; sometimes ↑ total lung capacity) consistent with small-airway narrowing. jhltonline.org

8. Diffusing capacity (DLCO). May be normal or mildly reduced; helps characterize overall gas-exchange impairment and exclude other causes. jhltonline.org

9. Six-minute walk test with oximetry. Documents exertional desaturation and exercise limitation; used for monitoring and oxygen qualification. jhltonline.org

10. Peak expiratory flow monitoring. Daily values are often persistently low with little variability, supporting fixed, not variable, obstruction. jhltonline.org

C) Laboratory & pathological tests

11. Infection work-up (blood, sputum, nasopharyngeal PCR). In transplant recipients, ruling out infection (bacterial, viral, fungal) is essential before diagnosing BOS. American Thoracic Society

12. Bronchoalveolar lavage (BAL) with cultures. Helps exclude infection and look for inflammatory patterns; part of the transplant evaluation pathway. American Thoracic Society

13. Transbronchial or surgical lung biopsy (selected cases). Histology may show concentric fibrous narrowing/obliteration of membranous bronchioles; not always required if clinical and imaging findings are classic. CDC

14. Autoimmune serologies (when clinically suspected). Tests for RA or other connective-tissue diseases when bronchiolitis accompanies joint/autoimmune features. publications.ersnet.org

15. Gastroesophageal reflux evaluation (as indicated). Because micro-aspiration can worsen BOS after transplant, reflux testing may be considered in some centers. jhltonline.org

D) Electrodiagnostic/physiologic monitoring

16. Resting and exertional pulse oximetry. Simple electrical sensors track oxygen saturation trends at rest and during walking, flagging exertional hypoxemia typical of small-airway disease. jhltonline.org

17. Capnography (selected settings). Continuous CO₂ tracing can reveal ventilation problems and support recognition of air-trapping physiology. jhltonline.org

18. Electrocardiogram (ECG) to exclude cardiac causes of dyspnea. While not diagnostic for BOS, ECG helps separate heart from lung causes when symptoms overlap. jhltonline.org

E) Imaging tests

19. **High-resolution CT (HRCT) of the chest with inspiratory and expiratory images. Mosaic attenuation and expiratory air-trapping are the classic patterns; bronchial wall thickening and cylindrical bronchiectasis may be present. Expiratory series are vital to see air trapping. ajronline.org+2sciencedirect.com+2

20. Serial HRCT for progression. Comparing scans over time can show widening air-trapping areas in parallel with falling FEV₁. Correlation studies link mosaic extent with worse spirometry. onlinelibrary.wiley.com

Non-pharmacological treatments (therapies and others)

1. Pulmonary rehabilitation. A supervised program of breathing exercises, walking, cycling, and strength work helps you breathe easier and do more daily tasks. It improves fitness, teaches energy-saving habits, and lowers breathlessness. It does not fix scarring, but it helps you live better with BOS. publications.ersnet.org

2. Breathing retraining (pursed-lip and diaphragmatic breathing). Slow, deep breathing with lips partly closed keeps airways open longer and reduces air trapping. It can lower the feeling of “air hunger” during exertion. Practice several short sessions daily. publications.ersnet.org

3. Airway clearance techniques. Huffs, cough cycles, and devices that vibrate the airways move mucus from small tubes to larger ones. Keeping the airways clear may reduce infections that can worsen BOS. publications.ersnet.org

4. Nutritional counseling. Small, frequent meals and balanced protein help you keep muscle and prevent unwanted weight loss or gain. Good nutrition supports immune health during intensive therapies. publications.ersnet.org

5. Vaccination schedule adherence. Staying up to date with influenza and pneumococcal vaccines (as advised by your transplant team) lowers infection risk, which can speed BOS decline. publications.ersnet.org

6. Trigger avoidance. Avoid smoke, dust, strong fumes, and sick contacts. Use masks in crowded indoor spaces during outbreaks. Reducing irritants may calm airway inflammation. publications.ersnet.org

7. Home air quality improvement. HEPA filtration, humidity control (about 40–50%), and regular cleaning reduce indoor triggers and allergens. publications.ersnet.org

8. Monitored exercise plan. A daily step goal plus light strength moves preserves function and prevents deconditioning without over-straining your breathing. publications.ersnet.org

9. Energy conservation training. Planning tasks, pacing, sitting for chores, and using mobility aids reduce fatigue and shortness of breath day-to-day. publications.ersnet.org

10. Sleep optimization. Good sleep hygiene and evaluation for sleep apnea (if snoring/daytime sleepiness) support recovery and immune balance. publications.ersnet.org

11. Psychological support. Counseling and peer groups help with stress, anxiety, and mood changes that are common in chronic breathlessness. publications.ersnet.org

12. Early infection action plan. Have a written plan for fevers, increased cough, or sputum change to get rapid care and limit flares. publications.ersnet.org

13. Environmental control at work/school. Ask for clean-air zones, avoid dusty tasks, and arrange rest breaks to control symptoms. publications.ersnet.org

14. Pulmonary function monitoring. Regular spirometry tracks FEV1 trends so your team can react early to changes. Home handheld spirometers may help in some settings. Default+1

15. High-resolution CT guidance. Periodic HRCT can show air trapping and mosaic attenuation, helping confirm BOS pattern and rule out other causes. PubMed

16. Comorbidity management. Treat reflux, sinus disease, or sleep apnea because they can worsen lung irritation and cough. publications.ersnet.org

17. Sun and skin protection during photosensitive therapies. If you receive photopheresis or certain drugs, protect skin and eyes as instructed. PubMed

18. Home oxygen when indicated. Oxygen reduces strain on the heart and improves exercise ability if blood oxygen is low at rest or with exertion. publications.ersnet.org

19. Extracorporeal photopheresis (ECP) care coordination. Though a procedure involving a machine, ECP is often grouped with “non-drug” immunomodulation in care plans; programs monitor blood counts, symptoms, and lung tests to judge benefit. PubMed+1

20. Transplant-center care pathways. Structured BOS clinics with protocolized assessments (symptoms, FEV1, imaging, infection screens) help standardize high-quality follow-up. Default

---

Drug treatments

Important: Most of these medicines are off-label for BOS but used based on transplant-society experience and studies. Always use the exact regimen your transplant center prescribes. FDA labels below support safety, class, and dosing details for the drugs themselves.

1. Azithromycin (macrolide). Often used as part of “FAM” therapy to calm airway inflammation and neutrophilic activity. Typical transplant protocols use 250–500 mg schedules several days per week; exact dose varies. Benefits may include FEV1 stabilization in some patients. Side effects can include GI upset and QT prolongation; review drug interactions. PMC+2sciencedirect.com+2

2. Fluticasone (inhaled corticosteroid). Reduces airway inflammation when combined with other agents in FAM bundles. Dose is device-specific; clinicians often pair with a LABA for delivery to small airways. Watch for hoarseness or thrush; rinse mouth after use. sciencedirect.com

3. Montelukast (leukotriene receptor blocker). Used in FAM bundles to block leukotriene-driven inflammation; common adult dose is 10 mg nightly. Can help symptoms but carries a boxed warning for serious neuropsychiatric events; discuss risks and stop if mood changes occur. FDA Access Data+2FDA Access Data+2

4. Budesonide/formoterol (ICS/LABA). Combines steroid anti-inflammatory effects with smooth-muscle relaxation for airflow improvement. Typical inhaled doses follow the device label; monitor for tremor, palpitations, and oral thrush. Not a rescue inhaler. FDA Access Data+1

5. Tiotropium (LAMA). A once-daily anticholinergic that relaxes airway smooth muscle and may reduce dynamic air trapping. In BOS it’s used off-label; follow COPD maintenance dosing per device. Side effects: dry mouth, urinary retention in susceptible patients. FDA Access Data+1

6. Short-acting bronchodilators (albuterol). Rescue relief for sudden breathlessness; use before exertion or as directed. Overuse signals poor control and needs reassessment. (General practice reference in BOS reviews.) publications.ersnet.org

7. Systemic corticosteroids (short pulse per protocol). Sometimes used briefly for new-onset decline, often within FAM protocols, aiming to blunt acute inflammatory surges; long-term courses are limited due to side effects. sciencedirect.com

8. Calcineurin inhibitor optimization (tacrolimus). Post-transplant immunosuppression is adjusted to protect the graft and may affect BOS course. Tacrolimus requires level monitoring and has infection and kidney risks; dosing and timing are individualized. FDA Access Data+1

9. mTOR-pathway management (sirolimus). Some centers adjust mTOR agents based on overall transplant needs; sirolimus has a boxed warning and is not recommended in lung transplant because of safety concerns—any change must be specialist-guided. FDA Access Data

10. Inhaled budesonide (nebulized or DPI). An option when higher local steroid exposure is desired with fewer systemic effects; watch for dysphonia and thrush. FDA Access Data

11. Formoterol or salmeterol (LABAs). Long-acting bronchodilators improve airflow but must be paired with an inhaled steroid in chronic use; follow label dosing and warnings. FDA Access Data

12. Ipratropium (short-acting anticholinergic). Can be used as scheduled or as-needed bronchodilator support, sometimes combined with albuterol in nebulizers for symptomatic relief. publications.ersnet.org

13. Antimicrobial therapy for infections. Rapid, targeted antibiotics or antivirals treat triggers that accelerate BOS decline; choices are culture-guided and center-specific. publications.ersnet.org

14. Prophylaxis per transplant protocol. Agents against Pneumocystis, CMV, and fungal infections are tailored to reduce infectious drivers of airway injury in BOS patients after transplant. publications.ersnet.org

15. Proton-pump inhibitor if reflux present. Treating reflux may lower micro-aspiration and airway irritation; dose and duration depend on symptoms and endoscopy findings. publications.ersnet.org

16. Macrolide class alternatives (e.g., clarithromycin) when azithromycin not tolerated. Selected for similar immunomodulatory effects, but interactions and side-effect profiles differ and must be checked carefully. publications.ersnet.org

17. Leukotriene-pathway alternatives. If montelukast is not suitable, specialists may consider other pathways or discontinue if no benefit; risk-benefit is reviewed regularly. Reuters

18. Inhaled triple therapy (ICS/LABA/LAMA). In selected cases, clinicians combine all three inhaled classes to maximize bronchodilation and anti-inflammation; this is off-label for BOS and closely monitored. publications.ersnet.org

19. Antifibrotic research pathways. Some centers evaluate agents in studies to slow small-airway fibrosis; these are investigational and not standard of care. publications.ersnet.org

20. Peri-therapeutic prophylaxis during ECP or intensified immunosuppression. Tailored antivirals/antimicrobials reduce complications while immunomodulatory therapies are given. PubMed

---

Dietary molecular supplements

1. Omega-3 fatty acids (EPA/DHA). May help lower airway inflammation and support heart health; typical food-first approach is fatty fish twice weekly; supplements only if approved. Watch for bleeding risk with anticoagulants. publications.ersnet.org

2. Vitamin D. Supports bone and immune health, often low in people avoiding sun or on steroids; dose is lab-guided to reach normal levels. publications.ersnet.org

3. Calcium. Protects bones when on steroids; use diet first, supplement if intake is low and your team agrees. publications.ersnet.org

4. Magnesium. Important for muscle and nerve function; tacrolimus can lower magnesium—repletion is blood-test guided. FDA Access Data

5. Zinc. Supports wound healing and immunity; excess can reduce copper—use only with clinician guidance. publications.ersnet.org

6. Probiotics (center-specific). Sometimes used to support gut health during antibiotics; choose products approved by your team. publications.ersnet.org

7. Protein supplements (whey/plant). Help maintain muscle if appetite is low; spread intake across meals. publications.ersnet.org

8. Sodium restriction (not a supplement but dietary strategy). Lower salt helps if steroids cause fluid retention or if oxygen levels drop with edema. publications.ersnet.org

9. Antioxidant-rich foods (berries, leafy greens). Food-based antioxidants support general health; supplements are not routinely advised unless prescribed. publications.ersnet.org

10. Caffeine timing for exertion (e.g., coffee/tea). Small amounts before exercise may reduce perceived breathlessness; avoid late-day caffeine to protect sleep. publications.ersnet.org

---

Drugs for immunity booster / regenerative / stem-cell related

1. Tacrolimus (calcineurin inhibitor). Maintains transplant immune balance to protect the graft and may influence BOS course; dosing is based on trough levels and organ type. Side effects include kidney strain, tremor, and infections. FDA Access Data

2. Sirolimus (mTOR inhibitor). An immunosuppressant that modulates cell growth pathways; not recommended in lung transplant due to safety warnings—changes require expert review. FDA Access Data

3. Systemic corticosteroids (short planned courses). Temporarily dampen immune responses during flares; long-term risks include diabetes, bone loss, and infection. sciencedirect.com

4. Extracorporeal photopheresis (procedure with photosensitizer/UV). Modulates immune cells outside the body and can slow FEV1 decline in some BOS cases; typically well tolerated; schedules vary by center. PubMed

5. Adjunct antimicrobial prophylaxis. Not classic “boosters,” but they protect you during immunomodulatory therapy by lowering infection risk. publications.ersnet.org

6. Clinical-trial biologics or cell-based therapies. Reserved for research settings when standard care fails; discuss eligibility at your transplant center. publications.ersnet.org

---

Surgeries/procedures (what they are, why done)

1. Extracorporeal photopheresis (ECP). Blood is treated with a light-activated medicine and UV-A, then returned. Used to modulate immune reactions in BOS and chronic graft-versus-host disease. Aim: slow lung decline when medicines are not enough. PubMed

2. Bronchoscopy with lavage/biopsy. A flexible scope checks for infections, rejects other causes of decline, and samples tissue or fluid. It guides therapy choices during BOS workups. publications.ersnet.org

3. Airway stenting (selected cases). If larger airway narrowing co-exists, a stent may improve flow; BOS targets small airways, so stents help only when big-airway lesions are present. publications.ersnet.org

4. Total lymphoid irradiation (rare, center-specific). Low-dose radiation to lymph tissues aims to reduce harmful immune activity; used only in carefully selected patients. publications.ersnet.org

5. Lung re-transplantation. Considered for severe, progressive BOS when other treatments fail and the patient is otherwise a candidate. It can restore function but carries major risks. publications.ersnet.org

---

Preventions

1. Keep every follow-up visit and do regular spirometry to spot decline early. Default

2. Vaccinate as advised by your transplant team (influenza, pneumococcal, others). publications.ersnet.org

3. Avoid smoke, vaping, and polluted air; use masks in risky settings. publications.ersnet.org

4. Wash hands and practice infection control at home and work. publications.ersnet.org

5. Treat reflux and sinus issues to reduce airway irritation. publications.ersnet.org

6. Follow your drug plan exactly; never change doses without your team. FDA Access Data

7. Exercise most days within your plan to keep muscles strong. publications.ersnet.org

8. Keep good nutrition and hydration. publications.ersnet.org

9. Act fast on fever, new cough, or sputum change—use your action plan. publications.ersnet.org

10. Maintain clean indoor air (HEPA filter, good ventilation, humidity control). publications.ersnet.org

---

When to see a doctor urgently

Seek same-day care for any of these: new or worsening shortness of breath at rest, oxygen saturation falling, chest pain, high fever, coughing up blood, severe wheeze not relieved by rescue inhaler, sudden FEV1 drop on home spirometry, confusion or fainting, or any serious side effect from medicines (such as mood or behavior changes on montelukast). Transplant recipients should contact their transplant center first. Default+2FDA Access Data+2

---

What to eat and what to avoid

Eat:

1. Lean proteins (fish, poultry, legumes) to maintain muscle. publications.ersnet.org

2. Whole grains for steady energy. publications.ersnet.org

3. Colorful fruits and vegetables for antioxidants. publications.ersnet.org

4. Healthy fats (olive oil, nuts; fish for omega-3s). publications.ersnet.org

5. Adequate calcium/vitamin D foods (dairy or fortified alternatives) if approved. publications.ersnet.org

Avoid/limit:

1. Tobacco, vaping, and exposure to smoke (not food, but critical). publications.ersnet.org
2. Very salty processed foods if you retain fluid on steroids. publications.ersnet.org
3. Alcohol excess (interacts with many drugs). publications.ersnet.org
4. Grapefruit and Seville orange products with tacrolimus/sirolimus (drug interactions). FDA Access Data+1
5. Raw or high-risk foods if your team restricts them during immunosuppression. publications.ersnet.org

---

Frequently asked questions

1. Is BOS the same as infection? No. Infections can trigger or mimic worsening, but BOS is chronic scarring and narrowing of small airways after transplant. Testing helps tell them apart. publications.ersnet.org

2. How do doctors diagnose BOS? Mainly by a persistent FEV1 drop from your best post-transplant value, plus imaging and exclusion of other causes. Default+1

3. What does the CT scan show? Air trapping and a patchwork (mosaic) look from uneven airflow, typical of small-airway disease. PubMed+1

4. Can BOS be cured? There is no simple cure yet. The aim is to slow decline, control symptoms, and protect the graft. Some people stabilize for long periods. publications.ersnet.org

5. What is FAM therapy? A common bundle combining inhaled fluticasone, azithromycin, and montelukast, sometimes with a brief steroid pulse, to reduce inflammation and airway hyper-responsiveness. PMC+1

6. Is montelukast safe? It can help some patients, but it carries a boxed warning for serious mental health side effects. Report mood or behavior changes right away. FDA Access Data+1

7. Why use azithromycin if I’m not infected? Low-dose macrolides have immune-modulating effects that can slow BOS in some people. Your team monitors for benefits and side effects. PMC

8. Will inhalers help if the problem is scarring? Inhalers don’t remove scar tissue, but they relax airway muscles and reduce inflammation, which can ease breathing and improve exercise tolerance. publications.ersnet.org

9. What is ECP and who gets it? Extracorporeal photopheresis treats blood outside the body with a light-activated drug and UV-A. It may stabilize lung function when medicines are not enough. PubMed

10. Do I need oxygen? Only if oxygen levels are low at rest or with activity. Testing guides this decision. Oxygen can reduce heart strain and improve stamina. publications.ersnet.org

11. Can exercise make me worse? With a supervised plan, exercise helps most people breathe better and live more actively. Stop if dizzy, very breathless, or chest-pain occurs. publications.ersnet.org

12. How often should I check my lungs? Follow your program’s schedule. Many centers check spirometry regularly; some use home FEV1 monitoring to catch early drops. Default

13. What about reflux? Treating reflux can reduce airway irritation and micro-aspiration, which may help control symptoms. publications.ersnet.org

14. Is re-transplantation an option? Yes, for severe, progressive BOS in selected candidates after thorough evaluation. It carries significant risks and requires lifelong care. publications.ersnet.org

15. What’s my outlook? It varies widely. Some people progress quickly; others stabilize with therapy and careful follow-up. Early detection and consistent care improve outcomes. Default

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: November 03, 2025.